Moore Paul Andrew sold ZYME
January 5, 2026 · Form 4 insider transaction
Moore Paul Andrew sold 9,289 shares of Zymeworks Inc. at $25.10 per share, a transaction worth $233.1K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 0 days after the transaction.
Footnotes
Represents shares of common stock sold to cover tax withholding obligations and other applicable fees in connection with the vesting of RSUs pursuant to mandatory "sell to cover" provisions contained in the Reporting Person's applicable RSU grant agreement, and does not represent a discretionary sale by the Reporting Person. The Reporting Person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than to cover required taxes and fees.; The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.715 to $25.84, inclusive. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.